Clinical Usefulness of Selective Plasma Exchange for Treating Pediatric Autoimmune Neurological Diseases
Therapeutic Apheresis and Dialysis · 2026-06 · 30 (3) · 412-417
DOI: 10.1002/1744-9987.70136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 19.03.2026. Verfasst von Tomoya Nakamizo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Plasma Exchange, Immunoglobulin G, Autoimmune Diseases of the Nervous System, Autoimmune Diseases. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Introduction
Selective plasma exchange (SePE) using the Evacure Plus EC‐4A10D selective membrane separator is a useful therapeutic option for removing immunoglobulin G (IgG) in autoimmune diseases while retaining coagulation factors, including fibrinogen. This study aimed to clarify the clinical usefulness of SePE in pediatric autoimmune neurological disorders.
Methods
We reported five pediatric patients with pediatric autoimmune neurological disorders successfully treated with SePE. We analyzed the removal rates of IgG and fibrinogen in a total of 29 SePE sessions and 3 conventional plasma exchange (PE) sessions performed on five pediatric patients.
Results
Clinical symptoms improved in all patients without coagulation factor supplementation, and no severe adverse events of SePE/PE were observed. The mean IgG removal rates were similar for SePE and PE, at 55.5% and 61.8%, respectively. In contrast, the mean fibrinogen removal rate was lower for SePE than for PE, at 17.9% and 61.3%, respectively.
Conclusions
SePE might be effective for pediatric autoimmune neurological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan.
- Medical Engineering Center, Medical Hospital of Institute of Science Tokyo, Tokyo, Japan.
- Department of Nephrology, Institute of Science Tokyo, Tokyo, Japan.
- Department of Pediatrics, Perinatal and Maternal Medicine, Institute of Science Tokyo, Tokyo, Japan.
ORCID-Profile: Tomohiro Udagawa, Tomoko Mizuno, Masatoshi Takagi, Masaki Shimizu
Zitieren
APA
Nakamizo, T., Kanamori, T., Kaneda, T., Osaka, K., Murakoshi, M., Okutsu, M., Ohkubo, A., Udagawa, T., Mizuno, T., Naito, S., Takagi, M., & Shimizu, M. (2026). Clinical Usefulness of Selective Plasma Exchange for Treating Pediatric Autoimmune Neurological Diseases. Therapeutic Apheresis and Dialysis, 30(3), 412-417. https://doi.org/10.1002/1744-9987.70136
Vancouver
Nakamizo T, Kanamori T, Kaneda T, Osaka K, Murakoshi M, Okutsu M, et al. Clinical Usefulness of Selective Plasma Exchange for Treating Pediatric Autoimmune Neurological Diseases. Therapeutic Apheresis and Dialysis. 2026;30(3):412-417. doi:10.1002/1744-9987.70136
BibTeX
@article{Nakamizo2026,
author = {Nakamizo, Tomoya and Kanamori, Toru and Kaneda, Tomoya and Osaka, Kei and Murakoshi, Miki and Okutsu, Mika and Ohkubo, Atsushi and Udagawa, Tomohiro and Mizuno, Tomoko and Naito, Shotaro and Takagi, Masatoshi and Shimizu, Masaki},
title = {Clinical Usefulness of Selective Plasma Exchange for Treating Pediatric Autoimmune Neurological Diseases},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
volume = {30},
number = {3},
pages = {412--417},
doi = {10.1002/1744-9987.70136}
}
EUVIMED